Invention Grant
- Patent Title: SMYD2 inhibitors
-
Application No.: US14812726Application Date: 2015-07-29
-
Publication No.: US09598381B2Publication Date: 2017-03-21
- Inventor: Gary G. Chiang , William N. Pappano , Ramzi F. Sweis , Zhi Wang
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Changxia Sun
- Main IPC: C07D209/40
- IPC: C07D209/40 ; C07D265/36 ; C07D295/13 ; C07D487/04 ; C07D401/12 ; C07D471/04 ; C07C255/58
Abstract:
The present disclosure generally relates to compounds having cellular anti-proliferative activities, and more particularly relates to compounds which inhibit the activity of human SMYD2, a SET and MYND domain-containing protein lysine methyltransferase.
Public/Granted literature
- US20160031838A1 SMYD2 INHIBITORS Public/Granted day:2016-02-04
Information query
